BioLife Solutions
BLFS
149 hedge funds and large institutions have $823M invested in BioLife Solutions in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 51 increasing their positions, 46 reducing their positions, and 9 closing their positions.
1,047% more call options, than puts
Call options by funds: $3.92M | Put options by funds: $342K
100% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 9
11% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 46
11% more capital invested
Capital invested by funds: $743M → $823M (+$79.8M)
6% more funds holding
Funds holding: 140 → 149 (+9)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3.5% less ownership
Funds ownership: 101.53% → 98.03% (-3.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
+$20.4M |
| 2 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$6.11M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$6.02M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$6.02M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$39.4M |
| 2 |
Millennium Management
New York
|
-$8.74M |
| 3 |
RA
Royce & Associates
New York
|
-$6.23M |
| 4 |
Morgan Stanley
New York
|
-$5.33M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.03M |
BLFS Hedge Fund Activity: Q1 2024 in Review
149 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2024, worth a combined $823M — up 11% from $743M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new BLFS positions and 9 closed out — a net gain of 9 holders — while 51 added to existing stakes and 46 trimmed.
The largest buyer was Cramer Rosenthal McGlynn, opening a new position worth an estimated $20.4M. The largest seller was Goldman Sachs, cutting an estimated $39.4M.
- 149 institutional investors held BioLife Solutions (BLFS) as of Q1 2024, up from 140 in Q4 2023.
- Funds reported $823M of BioLife Solutions stock for Q1 2024, up 11% quarter-over-quarter.
- 18 funds opened new BioLife Solutions positions in Q1 2024 and 9 closed out, a net change of +9 holders.
- The largest BioLife Solutions buyer in Q1 2024 was Cramer Rosenthal McGlynn, an estimated $20.4M added.
- The largest BioLife Solutions seller in Q1 2024 was Goldman Sachs, an estimated $39.4M sold.
Based on aggregated 13F filings for Q1 2024.